BRASKEM SA (BAK) is a Health Care company in the Industrial Organic Chemicals industry (SEC CIK 0001071438). Annual revenue was $77.41B in FY2024, compared to $58.54B in FY2020. Net income in FY2024 was $-12.05B.
| Metric | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 | FY20Dec '20 |
|---|---|---|---|---|---|
| Revenue | $77.41B | $70.57B | $96.52B | $105.63B | $58.54B |
| Gross Profit | $6.00B | $3.02B | $11.36B | $32.06B | $11.21B |
| Operating Income | $-1.08B | $-2.79B | $4.27B | $26.04B | $-0.07B |
| Net Income | $-12.05B | $-4.89B | $-0.82B | $13.96B | $-7.02B |
| EPS (Diluted) | — | — | — | $17.57 | $-8.41 |
| Metric | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 | FY20Dec '20 |
|---|---|---|---|---|---|
| Total Assets | $101.58B |
| Metric | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 | FY20Dec '20 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.44B |
| Metric | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 | FY20Dec '20 |
|---|---|---|---|---|---|
| Gross Margin | 7.7% | 4.3% |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 20-F | 0001292814-26-002427 | Dec 31, 2025 | Apr 20, 2026 | Apr 20, 2026 20:34 UTC | EDGAR |
| 20-F | 0001292814-25-001192 | Dec 31, 2024 | Mar 31, 2025 | Mar 29, 2025 01:59 UTC | EDGAR |
| 20-F | 0001292814-24-001348 | Dec 31, 2023 | Apr 12, 2024 | Apr 12, 2024 10:06 UTC | EDGAR |
| 20-F | 0001292814-23-001738 | Dec 31, 2022 | Apr 25, 2023 | Apr 25, 2023 00:34 UTC | EDGAR |
| 20-F | 0001292814-22-001862 | Dec 31, 2021 | Apr 28, 2022 | Apr 28, 2022 02:01 UTC | EDGAR |
| 20-F | 0001292814-21-002286 | Dec 31, 2020 | May 14, 2021 | May 14, 2021 01:17 UTC | EDGAR |
| 20-F | 0001292814-20-002229 | Dec 31, 2019 | Jun 15, 2020 | Jun 13, 2020 01:31 UTC | EDGAR |
| 20-F | 0001292814-19-003452 | Dec 31, 2018 | Oct 17, 2019 | Oct 17, 2019 21:27 UTC | EDGAR |
Direct links to SEC EDGAR. BAK has additional filings available on the SEC site.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $91.74B |
| $88.05B |
| $92.56B |
| $86.08B |
| Total Liabilities | — | — | $3.01B | $4.19B | — |
|---|
| Stockholders' Equity | $-4.28B | $3.28B | $6.11B | $6.21B | $-3.87B |
|---|
| Cash & Equivalents | $14.99B | $14.19B | $12.47B | $8.68B | $13.86B |
|---|
| Total Debt | — | — | — | — | — |
|---|
| $-2.27B |
| $8.95B |
| $14.79B |
| $6.29B |
| Capital Expenditures | $3.76B | $4.53B | $4.85B | $3.42B | $2.76B |
|---|
| Free Cash Flow | $-1.33B | $-6.80B | $4.10B | $11.37B | $3.53B |
|---|
| 11.8% |
| 30.3% |
| 19.2% |
| Operating Margin | -0.1% | -0.0% | -0.1% | 0.3% | -0.1% |
|---|
| Net Margin | -0.1% | -0.1% | -0.1% | 0.2% | -0.2% |
|---|
| Return on Equity | 281.7% | -149.1% | -13.4% | 225.0% | 181.5% |
|---|
| Return on Assets | -11.9% | -5.3% | -0.9% | 15.1% | -8.1% |
|---|
| Debt / Equity | — | — | 0.49× | 0.68× | — |
|---|
